Early-stage investment – impacts of Covid-19

Our research into the impact of the Covid-19 siutation on innovation-based companies shows that attracting investment and cash-flow are major concerns, based on our survey of Oxfordshire-based businesses.

The Government announced the Future Fund to support risk-capital backed companies on 20th April, 2020.  However, our early assessment suggests that this intervention is unlikely to support early-stage investment (pre-series A level investment) and companies that have not already raised at least £250k will not be eligible.  We are now reaching out to the investment community to gather their views on early-stage investment and the likely impact of Covid-19 on investment activity and decisions.

If you are an investor, please complete a short set of questions to contribute your insights and perspectives.

Click here to add your views

Recent news

Barclays opens its 25th Eagle Lab in Oxford

Barclays opens its 25th Eagle Lab in Oxford

Barclays Eagle Labs officially launches in Oxford at The Wood Centre for Innovation   Barclays Eagle Labs has opened its doors in Oxford at The Oxford Trust’s Wood Centre for Innovation in Headington’s Health & Life Sciences District. Oxford is one of a...

read more
Life Sciences company Evotec expands at Milton Park

Life Sciences company Evotec expands at Milton Park

Evotec, a leading drug discovery alliance and development partnership company, has taken additional office and laboratory space at Milton Park.  Milton Park is an Advanced Oxford member and one of the leading science and technology communities in Europe.  The...

read more

Advanced Oxford is a community interest company (CIC), number 10976883

© Advanced Oxford 2019 | Site by Herd